New Delhi, July 30, 2024: A study conducted by Tata Memorial Hospital in Mumbai has shown that adding Nimotuzumab to the standard treatment regimen significantly improves the 10-year overall survival
Continue ReadingTata Memorial Study: Nimotuzumab Boosts Survival in Head and Neck Cancer